Biologics Spine Peer-Reviewed Publication Demonstrating Long-Term Fusion Outcomes with VIA Form+™ in Lumbar Interbody Fusion byJosh SandbergFebruary 12, 2026
Biologics Spine BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease byTim AllenFebruary 10, 2026
Biologics Top Stories XLTA® Announces Distributor Partnership with Total Ancillary, Expanding Access to Advanced Hydrocapillary Wound Care byJosh SandbergFebruary 4, 2026
Biologics Spine Top Stories Nivalon Medical Produces the World’s First Fully Patient-Specific, Motion-Preserving, Metal-Free Spinal Implant Using AI and Advanced Ceramic 3D Printing byJosh SandbergJanuary 30, 2026
Biologics Spine Study Shows NanoFuse® Superiority: Why Bioactive Glass-DBM Composites Outperform DBM and Bioactive Glass Alone byJosh SandbergJanuary 26, 2026
Biologics Spine Spine Biologic Market Report 2026 – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 byTim AllenJanuary 26, 2026
Biologics Royal Biologics Announces Exclusive U.S. Distribution Agreement with Aroa Biosurgery for Myriad Matrix™ Restore byTim AllenJanuary 15, 2026
Biologics Spine MTF Biologics and Kolosis BIO Launch New Solution for Orthopedic and Spinal Surgeries: Summit Matrix™ byJosh SandbergJanuary 14, 2026
Biologics Regulatory Spine Top Stories Cerapedics’ PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use byTim AllenJanuary 13, 2026
Biologics Spine Top Stories ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion byJosh SandbergJanuary 12, 2026